TMDX (TransMedics Group, Inc.) Stock Financials & Earnings

TMDXTransMedics Group, Inc.

Mkt Cap$5B

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$605M

Net Income (TTM)$190M

EPS (TTM)$4.87

Free Cash Flow (TTM)$134M

Gross Margin59.9%

Op. Margin17.9%

Net Margin31.4%

FCF Margin22.1%

P/S Ratio (TTM)7.5x

P/E Ratio (TTM)23.9x

YoY Rev Growth+37.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$42M	$29M	-$2M
Q2 23	$52M	$37M	-$906K
Q3 23	$66M	$41M	-$28M
Q4 23	$81M	$48M	$3M
Q1 24	$97M	$60M	$12M
Q2 24	$114M	$69M	$13M
Q3 24	$109M	$61M	$4M
Q4 24	$122M	$72M	$9M
Q1 25	$144M	$88M	$27M
Q2 25	$157M	$97M	$37M
Q3 25	$144M	$85M	$23M
Q4 25	$161M	$93M	$21M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$6M	$25M	—	—
Q2 23	$8M	$28M	$1M	—
Q3 23	$38M	$31M	—	—
Q4 23	$11M	$35M	—	—
Q1 24	$11M	$36M	—	—
Q2 24	$14M	$43M	—	—
Q3 24	$14M	$43M	—	—
Q4 24	$16M	$47M	—	—
Q1 25	$17M	$44M	—	—
Q2 25	$16M	$44M	—	—
Q3 25	$15M	$45M	$1M	—
Q4 25	$21M	—	—	$51M

Revenue Segments

Revenue by Geography

Quarter	Other Countries	United States
Q1 23	$4M	$38M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$195M	$0	$195M
Q2 23	$582M	$0	$582M
Q3 23	$427M	$0	$427M
Q4 23	$395M	$0	$395M
Q1 24	$350M	$0	$350M
Q2 24	$363M	$0	$363M
Q3 24	$330M	$0	$330M
Q4 24	$337M	$0	$337M
Q1 25	$310M	$0	$310M
Q2 25	$401M	$0	$401M
Q3 25	$466M	$0	$466M
Q4 25	$488M	$0	$488M

Shares Outstanding

Revenue Per Employee

Revenue / Employee